Study guide
15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling
CCI Registered Cardiac Sonographer RCS
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: RCS Orientation and Clinical Context
1.1 RCS Identity, Exam Format, Application, and Retesting 1.2 Clinical History, Symptoms, Indications, and Risk Factors 1.3 Prior Studies, Serial Change, and Cross-Modality Context
2 Chapter 2: Orders, Safety, and Patient Preparation
2.1 Order Verification, Scope, and Protocol Selection 2.2 Sonographer Ergonomics and Staff Safety 2.3 Patient Preparation, Positioning, Consent, Infection Control, and Aftercare
3 Chapter 3: Reporting and 2-D TTE Foundations
3.1 Structured Findings, Significant Results, and Escalation 3.2 Standard 2-D TTE Windows, Views, and Acquisition Sequence 3.3 2-D Measurements, Foreshortening, Image Quality, and QA
4 Chapter 4: M-Mode and Doppler Acquisition
4.1 M-Mode Alignment, Timing, Measurements, and Pitfalls 4.2 Color Doppler Acquisition, Scale, Gain, and Jet Display 4.3 PW and CW Spectral Doppler Acquisition
5 Chapter 5: Advanced Doppler and Contrast
5.1 Tissue Doppler and Hemodynamic Sample Placement 5.2 Ultrasound-Enhancing Agents and LV Opacification 5.3 Agitated-Saline Studies and Intracardiac Shunts
6 Chapter 6: Stress Echocardiography
6.1 Exercise Stress Echo Protocols and Peak Imaging 6.2 Pharmacologic Stress Echo, Dobutamine, and Safety 6.3 Non-Ischemic Stress Echo and Hemodynamic Provocation
7 Chapter 7: TEE, Strain, and 3-D TEE
7.1 Assisting TEE: Preparation, Probe Safety, Views, and Complications 7.2 Strain Acquisition, Tracking Quality, and Reproducibility 7.3 3-D TEE Acquisition, Cropping, Orientation, and Artifacts
8 Chapter 8: 3-D TTE and the Aortic Valve
8.1 3-D TTE Full-Volume Acquisition and Quantitation 8.2 Aortic-Valve Anatomy, Morphology, and Function 8.3 Aortic Stenosis: Velocities, Gradients, Valve Area, and Flow States
9 Chapter 9: Aortic Regurgitation and Mitral Structure
9.1 Aortic Regurgitation Mechanisms and Integrated Severity 9.2 Mitral-Valve Anatomy, Motion, and Mechanisms 9.3 Mitral Stenosis: Planimetry, Gradients, Pressure Half-Time, and Suitability
10 Chapter 10: Mitral and Tricuspid Valve Findings
10.1 Mitral Regurgitation Mechanism, Quantitation, and Severity Integration 10.2 Tricuspid-Valve Anatomy, Structure, and Function 10.3 Tricuspid Stenosis Assessment
11 Chapter 11: Right-Sided Valve Disease
11.1 Tricuspid Regurgitation Mechanism and Severity 11.2 Pulmonic-Valve Anatomy, Structure, and Function 11.3 Pulmonic Stenosis Assessment
12 Chapter 12: Pulmonic Regurgitation and Prosthetic Valves
12.1 Pulmonic Regurgitation Mechanism and Severity 12.2 Normal Mechanical and Bioprosthetic Valve Assessment 12.3 Prosthetic Obstruction, Regurgitation, Thrombosis, and Patient–Prosthesis Mismatch
13 Chapter 13: Endocarditis and Cardiac Chambers
13.1 Valvular Endocarditis, Vegetations, Abscess, and Complications 13.2 LV and LA Size, Geometry, Volumes, Mass, and Function 13.3 RV and RA Size, Pressure, Volume, and Function
14 Chapter 14: Cardiomyopathy Phenotypes and Diastology
14.1 Dilated and Hypertrophic Cardiomyopathies, SAM, and LVOT Obstruction 14.2 Restrictive, Arrhythmogenic, and Stress Cardiomyopathies 14.3 Diastolic Function, Filling Pressure, Grading, and Pitfalls
15 Chapter 15: Systolic Function and Ischemia
15.1 LV Systolic Function, Simpson EF, Regional Motion, and Output 15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling 15.3 Ischemic Heart Disease, Coronary Territories, Stress Response, and Complications
16 Chapter 16: Pericardium and Great Vessels
16.1 Pericardial Effusion, Tamponade, Constriction, and Doppler Physiology 16.2 Great Vessels, Venous Return, and Pulmonary Artery Assessment 16.3 Aortic Root, Aneurysm, Dissection, and Coarctation
17 Chapter 17: Pulmonary Pressure, Masses, and Congenital Recognition
17.1 Pulmonary Hypertension, RAP/PASP Estimation, and RV Consequences 17.2 Cardiac Masses, Thrombus, Tumor, Vegetation, and Mimics 17.3 Adult Recognition of ASD, VSD, PFO, PDA, and Congenital Clues
18 Chapter 18: Devices, Strain, and Hemodynamics
18.1 ICDs, Pacemakers, Occluders, Closure Devices, and Mechanical Support 18.2 Strain Interpretation, Global Longitudinal Strain, and Disease Patterns 18.3 Cardiac Hemodynamics, Bernoulli, Continuity, Stroke Volume, and Shunts
19 Chapter 19: Infiltrative Disease and Physics Foundations
19.1 Amyloid, Sarcoid, and Other Infiltrative Disease Patterns 19.2 Ultrasound Wave Properties, Propagation, Frequency, and Wavelength 19.3 Artifact Recognition: Reverberation, Shadowing, Mirror, Refraction, and Aliasing
20 Chapter 20: Resolution and Doppler Optimization
20.1 Axial/Lateral Resolution, Frame Rate, Depth, Focus, and Trade-Offs 20.2 Spectral Doppler Optimization, Nyquist, Filters, Gain, and Angle 20.3 Color Doppler Optimization, Scale, Priority, Variance, and Gain
21 Chapter 21: 2-D, 3-D, and Contrast Optimization
21.1 2-D Optimization: Frequency, Gain, TGC, Harmonics, Depth, and Focus 21.2 3-D Optimization: Volume Rate, Stitching, Cropping, and Display 21.3 Contrast Optimization: Mechanical Index, Destruction, Replenishment, and Artifacts
15.2 RV Systolic Function: TAPSE, S-prime, FAC, and Coupling
Key Takeaways Explain This Topic AI
Acquire an RV-focused, nonforeshortened apical view and record loading, rhythm, respiration, ventilation, TR, and pulmonary hemodynamics before interpreting systolic measures.
TAPSE and S′ are basal longitudinal surrogates, while FAC samples focused-plane area change; angle, translation, borders, surgery, leads, and load create different failure modes.
Valid FAC, 3-D RVEF, strain, and visual motion prevent one normal or abnormal annular metric from becoming a standalone conclusion.
TAPSE/PASP estimates RV-PA coupling only when both TAPSE and PASP are defensible; it is a contextual prognostic surrogate rather than direct pressure-volume measurement or universal diagnostic threshold.
Last updated: July 2026
Acquire the RV-focused view first
Right ventricular systolic function reflects longitudinal shortening, radial inward motion, anteroposterior shortening, and interaction with the septum. The RV's crescent geometry prevents one 2-D plane or one surrogate from representing all components. From a conventional apical four-chamber view, move laterally and rotate until the entire free wall is visible throughout the cycle, the RV basal diameter is maximized, and neither LVOT nor coronary sinus creates an oblique plane. Keep the apex and both tricuspid annuli in view. Foreshortening, a different rib space, and inconsistent rotation change TAPSE alignment and FAC area, so save landmarks for serial studies.
Record rhythm, respiration, blood pressure, oxygen or ventilation state, and recent loading treatment. RV function is highly afterload sensitive: acute pulmonary pressure elevation may abruptly reduce output, while severe TR can unload systolic ejection into the RA and make some motion indices appear better than effective forward performance. Preload, positive-pressure ventilation, pericardial constraint, LV function, and septal mechanics also change the result. Assess RV size, wall thickness, septal shape, TR severity, pulmonary hemodynamics, and IVC findings with function.
Measure three complementary mechanics
Measure Acquisition Current normal reference Principal limitation
TAPSE M-mode cursor through lateral tricuspid annulus, aligned with longitudinal annular motion; measure end-diastole to peak systole >1.7 cm Basal longitudinal surrogate; angle, translation, load, tethering, surgery, and leads
TDI S′ PW tissue sample at lateral annulus in an RV-focused view, Doppler beam parallel to motion >9.5 cm/s Basal peak velocity; angle, gain, filters, tethering, and load
FAC Trace RV area at end-diastole and end-systole in the same focused plane >35% Plane and border dependent; omits RVOT and is not a true volume EF
TAPSE measures distance, whereas S′ measures peak velocity; they are related but not interchangeable. For TAPSE, do not angle-correct a poorly aligned M-mode cursor. Verify that the annulus, not a lead or adjacent tissue, is tracked. For S′, place a small sample in the basal free-wall myocardium at the annulus, lower wall filters appropriately, and trace the peak systolic tissue signal rather than a valve click or isovolumic spike. Both measures sample one basal region and can miss apical or RVOT dysfunction.
For FAC, use [(RV end-diastolic area − RV end-systolic area) / RV end-diastolic area] × 100 . Trace from lateral annulus around the free wall and apex to the septal annulus; include trabeculations, papillary muscles, and moderator band within the cavity. Use maximum and minimum cavity frames and the same plane for both. Endocardial dropout, heavy trabeculation, and foreshortening change both areas. FAC includes longitudinal and radial change but excludes the RVOT, so it is broader than TAPSE without becoming a full-volume RVEF.
Add 3-D RVEF and RV free-wall strain when feasible. A current normal 3-D RVEF is greater than 45%, and normal free-wall strain is more negative than approximately −20%, using the laboratory's convention. Three-dimensional data require the entire inflow, body, apex, and outflow without dropout or stitching and may underestimate volume compared with CMR. Strain requires adequate frame rate and tracking and varies with vendor and load. Visual free-wall thickening remains important, especially when regional infarction or postoperative geometry makes annular surrogates discordant.
Use discordance as a prompt to investigate
A normal TAPSE cannot overrule abnormal FAC, 3-D RVEF, strain, and visual motion when those acquisitions are valid. Conversely, low TAPSE or S′ immediately after cardiac surgery or pericardiotomy may reflect altered annular translation more than proportional global RVEF loss. Severe TR, a trans-tricuspid lead, pacing, pericardial disease, RV pressure overload, and LV tethering can separate the metrics. Recheck plane, alignment, border, timing, and representative beats before explaining the physiology. Report each valid value rather than averaging unlike percentages, centimeters, and velocities into a synthetic grade.
Relate contraction to pulmonary afterload
RV-pulmonary artery coupling describes whether RV contractile response is adequate for pulmonary afterload. The noninvasive TAPSE/PASP ratio divides TAPSE in millimeters by estimated pulmonary artery systolic pressure in mm Hg. Healthy cohorts generally fall around 0.5–0.7 mm/mm Hg; values around 0.3–0.4 mm/mm Hg in pulmonary hypertension are associated with uncoupling and increased risk. These are physiologic and prognostic ranges, not a universal diagnostic switch. Age, sex, body habitus, disease, and method change the optimal threshold.
The ratio is meaningful only when both inputs are valid and acquired under the same loading state. PASP requires a complete, aligned TR CW envelope plus a defensible RAP estimate and approximates pulmonary artery pressure only without pulmonic or RVOT obstruction. Severe free TR, an incomplete envelope, uncertain IVC response, or outflow obstruction can make the denominator misleading. TAPSE carries its own basal and angle limitations. FAC/PASP or strain/PASP may add information in specialized practice, but no coupling surrogate directly replaces pressure-volume loops or right-heart catheterization.
Conclude with an integrated statement: RV size and remodeling, visual function, TAPSE, S′, FAC, 3-D RVEF or strain when available, TR, estimated pressure, coupling confidence, rhythm, loading, and image limitations. Serial change is strongest when the focused plane, software, respiratory state, and treatment context match. A defensible examination identifies concordance, explains credible disagreement, and avoids diagnosing or prognosticating from one metric.
A coupling ratio inherits two sets of error
TAPSE/PASP is unreliable if annular tracking is off-axis or if PASP is based on an incomplete TR envelope, uncertain RAP, severe free TR, or RV outflow obstruction. Validate both inputs before interpreting the ratio.